Your session is about to expire
← Back to Search
Exercise Intervention for Cardiometabolic Health
N/A
Waitlist Available
Led By Jingyi Qian, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up about 12 and 24 hours after exercise
Awards & highlights
Summary
This trial seeks to understand how physical activity affects the body's natural clock. Participants will stay in-hospital, exercise, and provide samples.
Who is the study for?
This trial is for healthy adults aged 20-45 with a BMI of 20-34.9, without any serious health issues like heart disease or cancer. Participants must be willing to follow the study's rules, including staying in the hospital and doing moderate exercise.
What is being tested?
The study aims to see how our body clocks affect physical activity by having participants stay twice in a clinic, do some exercise, eat set meals, and give blood, urine, and saliva samples for testing.
What are the potential side effects?
Since this is an exercise intervention study focusing on healthy individuals without underlying conditions, significant side effects are not expected. However, typical reactions might include muscle soreness or fatigue from the physical activities.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ about 12 and 24 hours after exercise
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 12 and 24 hours after exercise
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
glucose level
mean arterial pressure
Secondary study objectives
autonomic nervous system activity
beta-cell function index
insulin sensitivity index
+1 moreOther study objectives
respiratory exchange ratio
resting energy expenditure
Trial Design
2Treatment groups
Experimental Treatment
Group I: Exercise B-A InterventionExperimental Treatment1 Intervention
The Exercise B first, then the Exercise A intervention.
Group II: Exercise A-B InterventionExperimental Treatment1 Intervention
The Exercise A first, then the Exercise B intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise intervention
2010
Completed Phase 4
~2160
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,653 Previous Clinical Trials
11,491,009 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,181 Total Patients Enrolled
Jingyi Qian, PhDPrincipal InvestigatorBrigham and Women's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any serious long-term health conditions.I have been hospitalized due to COVID-19.I am currently smoking/vaping or have smoked/vaped for 5+ years.I am between 20 and 45 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise A-B Intervention
- Group 2: Exercise B-A Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger